From cancer to COVID-19, ImmunoScape’s Deep Immunomics platform sheds new light on individual responses to treatments and vaccines, creating breakthroughs in the fight against disease.
Researchers were surprised to find memory T-cells in people with no history of SARS, COVID-19, or contact with SARS or COVID-19 patients.
This multi-institutional effort draws upon deep capabilities in skin research and cancer biology from Singapore and South Korea.
Three Singapore-based teams working on myopia, cancer and liver disease will receive funding over the next three years.
Fetuses have immune cells that can launch an effective attack against infectious agents and yet do not react against maternal cells.
Tessa Therapeutics has fully acquired Euchloe Bio, a biotech company focused on developing and commercializing therapeutic antibodies.
When faced with a lack of certain ‘essential’ genes, yeast cells can cope by simply doubling up their chromosomes.